16/04/2026
Our Representation Layer Extends to a New Domain: 8 Therapies
Alphabiome extends its reference-free intelligence layer to a new domain, turning raw genetic signal into response prediction across three indications and 8 therapies.
Building the biological data layer for AI
Alphabiome is the AI layer for drug development. We read the raw bacterial, viral, and host DNA that has no reference map, computing over signal others cannot, to reveal which therapies work, in which patients and why.
Discover Alphabiome
Learn more about how Alphabiome’s groundbreaking technology is opening new frontiers in precision medicine.
Reading the biology that decides who responds
The biology that determines treatment response is hidden in raw genetic signal. Alphabiome reads it reference-free, across human, bacterial, viral, and fungal DNA, finding the patterns that separate responders from non-responders and turning them into predictive intelligence for drug development.
What We Do
- Tokenize raw genetic sequencing data directly, reference-free, across human, bacterial, viral, fungal and other DNA.
- Learn latent biological structure across trillions of DNA fragments, beyond species, genes, pathways and reference genomes.
- Convert raw DNA data into AI-usable tokens that can power prediction, stratification, mechanism discovery and therapeutic decision-making.
Science & News
06/05/2025
AI That Predicts Drug Response from Raw Genetic Signal
Health Technology Net- Alphabiome’s engine reads raw, unannotated DNA beyond reference genomes, delivering unmatched signal for AI drug-response prediction.
06/05/2025
Alphabiome Unveils Revolutionary AI for Reference-Free Decoding
Alphabiome tokenizes raw genetic sequence that today’s biology AI can’t read, to accurately predict response.
21/11/2025
Peer-Reviewed: Reference-Free AI Validated at Scale
A peer-reviewed study validated Alphabiome’s reference-free AI across 10 farms and 339 animals, predicting response directly from raw DNA signal.
07/05/2025
Alphabiome Raises $8M to Build the Biological AI Layer
Finsmes.com- Alphabiome secures seed funding to expand R&D and build the representation layer between raw genetic signal and biological AI.
04/02/2026
Clinical Study: Our AI Predicts Response Across 7 Biologics
In a leading-hospital study, Alphabiome’s AI predicted response across seven biologic drugs, showing up to 3x higher accuracy than state-of-the-art models.
25/09/2025
Independent Validation: Our Reference-Free AI Predicts Again
A controlled trial validated Alphabiome’s reference-free AI on a second compound — an independent test of the same engine on new raw sequence.
25/11/2025
Predicting Response Straight from Raw DNA Signal
Alphabiome’s reference-free AI now reaches human disease. Our tokenization engine reads raw DNA the rest of biology AI can’t, then predicts response.
Our Partners
